139 related articles for article (PubMed ID: 35582224)
1. Progress in Glioma Stem Cell Research.
Ramar V; Guo S; Hudson B; Liu M
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201528
[TBL] [Abstract][Full Text] [Related]
2. ELTD1 as a multi-focal target for malignant gliomas: preclinical studies.
Zalles M; Smith N; Saunders D; Guzman M; Lerner M; Fung KM; Babu A; Battiste J; Chung J; Hwang K; Jin J; Towner RA
Neurooncol Adv; 2021; 3(1):vdab132. PubMed ID: 34704036
[TBL] [Abstract][Full Text] [Related]
3. ELTD1 Review: New Regulator of Angiogenesis in Glioma.
Buzatu I; Tache DE; Manea Carneluti EV; Zlatian O
Curr Health Sci J; 2023; 49(4):495-502. PubMed ID: 38559823
[TBL] [Abstract][Full Text] [Related]
4. Overcoming drug resistance in glioblastoma: new options in sight?
Kopecka J; Riganti C
Cancer Drug Resist; 2021; 4(2):512-516. PubMed ID: 35582029
[No Abstract] [Full Text] [Related]
5. MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells.
Djediai S; Gonzalez Suarez N; El Cheikh-Hussein L; Rodriguez Torres S; Gresseau L; Dhayne S; Joly-Lopez Z; Annabi B
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884812
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials.
Cruz Da Silva E; Mercier MC; Etienne-Selloum N; Dontenwill M; Choulier L
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918704
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide resistance in glioblastoma multiforme.
Lee SY
Genes Dis; 2016 Sep; 3(3):198-210. PubMed ID: 30258889
[TBL] [Abstract][Full Text] [Related]
8. Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration.
Bazan NG; Reid MM; Flores VAC; Gallo JE; Lewis W; Belayev L
Cancer Metastasis Rev; 2021 Sep; 40(3):643-647. PubMed ID: 34519960
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches to combat chemoresistance against glioblastomas.
Towner RA; Zalles M; Saunders D; Smith N
Cancer Drug Resist; 2020; 3(4):686-698. PubMed ID: 35582224
[TBL] [Abstract][Full Text] [Related]
10. A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007.
Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Battiste J; Towner RA
J Cell Mol Med; 2022 Jan; 26(2):570-582. PubMed ID: 34910361
[TBL] [Abstract][Full Text] [Related]
11. OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth.
Towner RA; Smith N; Saunders D; Brown CA; Cai X; Ziegler J; Mallory S; Dozmorov MG; Coutinho De Souza P; Wiley G; Kim K; Kang S; Kong DS; Kim YT; Fung KM; Wren JD; Battiste J
Transl Oncol; 2019 Feb; 12(2):320-335. PubMed ID: 30468988
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
13. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
14. Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.
Alafate W; Wang M; Zuo J; Wu W; Sun L; Liu C; Xie W; Wang J
Pathol Res Pract; 2019 Nov; 215(11):152617. PubMed ID: 31563286
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
